The aetiology of DISH remains largely unknown.[1]Le HV, Wick JB, Van BW, et al. Diffuse idiopathic skeletal hyperostosis of the spine: pathophysiology, diagnosis, and management. J Am Acad Orthop Surg. 2021 Dec 15;29(24):1044-51.
http://www.ncbi.nlm.nih.gov/pubmed/34559699?tool=bestpractice.com
[2]Kuperus JS, Mohamed Hoesein FAA, de Jong PA, et al. Diffuse idiopathic skeletal hyperostosis: etiology and clinical relevance. Best Pract Res Clin Rheumatol. 2020 Jun;34(3):101527.
https://www.sciencedirect.com/science/article/pii/S1521694220300449
http://www.ncbi.nlm.nih.gov/pubmed/32456997?tool=bestpractice.com
Several possible contributory factors to the development of the condition have been implicated, including genetic, metabolic, hormonal, inflammatory, and signal transduction system aberrations, as well as vascular and mechanical effects.[1]Le HV, Wick JB, Van BW, et al. Diffuse idiopathic skeletal hyperostosis of the spine: pathophysiology, diagnosis, and management. J Am Acad Orthop Surg. 2021 Dec 15;29(24):1044-51.
http://www.ncbi.nlm.nih.gov/pubmed/34559699?tool=bestpractice.com
[2]Kuperus JS, Mohamed Hoesein FAA, de Jong PA, et al. Diffuse idiopathic skeletal hyperostosis: etiology and clinical relevance. Best Pract Res Clin Rheumatol. 2020 Jun;34(3):101527.
https://www.sciencedirect.com/science/article/pii/S1521694220300449
http://www.ncbi.nlm.nih.gov/pubmed/32456997?tool=bestpractice.com
Vitamin A toxicity as well as use of vitamin A derivatives such as retinoids may also have a role in the disease process.[11]Nesher G, Zuckner J. Rheumatologic complications of vitamin A and retinoids. Semin Arthritis Rheum. 1995 Feb;24(4):291-6.
http://www.ncbi.nlm.nih.gov/pubmed/7740309?tool=bestpractice.com
[12]Abiteboul M, Arlet J, Sarrabay MA, et al. Metabolism of vitamin A in Forestier-Rotès-Quérol hyperostosis [in French]. Rev Rhum Mal Osteoartic. 1986 Mar;53(3):143-5.
http://www.ncbi.nlm.nih.gov/pubmed/3486449?tool=bestpractice.com
[13]Ling TC, Parkin G, Islam J, et al. What is the cumulative effect of long-term, low-dose isotretinoin on the development of DISH? Br J Dermatol. 2001 Mar;144(3):630-2.
http://www.ncbi.nlm.nih.gov/pubmed/11260033?tool=bestpractice.com
Exposure to fluoride has been suggested as a potential contributor to the development of DISH; however, no clear evidence of this has been found to date.
Growth hormone, which has been identified as being elevated in the serum and synovial fluid of patients with DISH, may stimulate osteoblast proliferation, which subsequently might result in excessive ossification.[9]Mader R, Verlaan JJ, Buskila D. Diffuse idiopathic skeletal hyperostosis: clinical features and pathogenic mechanisms. Nat Rev Rheumatol. 2013 Dec;9(12):741-50.
http://www.ncbi.nlm.nih.gov/pubmed/24189840?tool=bestpractice.com
The key risk factors for developing DISH are age >50 years, male sex, and obesity.[2]Kuperus JS, Mohamed Hoesein FAA, de Jong PA, et al. Diffuse idiopathic skeletal hyperostosis: etiology and clinical relevance. Best Pract Res Clin Rheumatol. 2020 Jun;34(3):101527.
https://www.sciencedirect.com/science/article/pii/S1521694220300449
http://www.ncbi.nlm.nih.gov/pubmed/32456997?tool=bestpractice.com
[6]Hirasawa A, Wakao N, Kamiya M, et al. The prevalence of diffuse idiopathic skeletal hyperostosis in Japan - the first report of measurement by CT and review of the literature. J Orthop Sci. 2016 May;21(3):287-90.
https://www.sciencedirect.com/science/article/pii/S094926581600018X
http://www.ncbi.nlm.nih.gov/pubmed/26948246?tool=bestpractice.com
[7]Hirasawa A, Robinson Y, Olerud C, et al. Regional differences in diffuse idiopathic skeletal hyperostosis: a retrospective cohort study from Sweden and Japan. Spine (Phila Pa 1976). 2018 Dec 15;43(24):E1474-8.
http://www.ncbi.nlm.nih.gov/pubmed/29916957?tool=bestpractice.com
[8]Kim SK, Choi BR, Kim CG, et al. The prevalence of diffuse idiopathic skeletal hyperostosis in Korea. J Rheumatol. 2004 Oct;31(10):2032-5.
https://www.jrheum.org/content/jrheum/31/10/2032.full.pdf
http://www.ncbi.nlm.nih.gov/pubmed/15468371?tool=bestpractice.com
[14]Belanger TA, Rowe DE. Diffuse idiopathic skeletal hyperostosis: musculoskeletal manifestations. J Am Acad Orthop Surg. 2001 Jul-Aug;9(4):258-67.
http://www.ncbi.nlm.nih.gov/pubmed/11476536?tool=bestpractice.com
[15]Westerveld LA, van Ufford HM, Verlaan JJ, et al. The prevalence of diffuse idiopathic skeletal hyperostosis in an outpatient population in The Netherlands. J Rheumatol. 2008 Aug;35(8):1635-8.
https://www.jrheum.org/content/jrheum/35/8/1635.full.pdf
http://www.ncbi.nlm.nih.gov/pubmed/18528963?tool=bestpractice.com
Diabetes mellitus, metabolic syndrome, and hypertension are associated conditions,and may have a role in the disease process; these conditions may often precede the diagnosis of DISH.[2]Kuperus JS, Mohamed Hoesein FAA, de Jong PA, et al. Diffuse idiopathic skeletal hyperostosis: etiology and clinical relevance. Best Pract Res Clin Rheumatol. 2020 Jun;34(3):101527.
https://www.sciencedirect.com/science/article/pii/S1521694220300449
http://www.ncbi.nlm.nih.gov/pubmed/32456997?tool=bestpractice.com
[16]Fassio A, Adami G, Idolazzi L, et al. Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker. Calcif Tissue Int. 2021 Feb;108(2):231-9.
http://www.ncbi.nlm.nih.gov/pubmed/33047242?tool=bestpractice.com
[17]Okada E, Ishihara S, Azuma K, et al. Metabolic syndrome is a predisposing factor for diffuse idiopathic skeletal hyperostosis. Neurospine. 2021 Mar;18(1):109-16.
https://e-neurospine.org/journal/view.php?doi=10.14245/ns.2040350.175
http://www.ncbi.nlm.nih.gov/pubmed/33211945?tool=bestpractice.com
A weaker risk factor is possible genetic predisposition.[2]Kuperus JS, Mohamed Hoesein FAA, de Jong PA, et al. Diffuse idiopathic skeletal hyperostosis: etiology and clinical relevance. Best Pract Res Clin Rheumatol. 2020 Jun;34(3):101527.
https://www.sciencedirect.com/science/article/pii/S1521694220300449
http://www.ncbi.nlm.nih.gov/pubmed/32456997?tool=bestpractice.com
Single-nucleotide polymorphisms in the COL6A1 and FGF2 genes may be linked to the development of DISH, according to preliminary data.[2]Kuperus JS, Mohamed Hoesein FAA, de Jong PA, et al. Diffuse idiopathic skeletal hyperostosis: etiology and clinical relevance. Best Pract Res Clin Rheumatol. 2020 Jun;34(3):101527.
https://www.sciencedirect.com/science/article/pii/S1521694220300449
http://www.ncbi.nlm.nih.gov/pubmed/32456997?tool=bestpractice.com
[4]Mader R, Verlaan JJ, Eshed I, et al. Diffuse idiopathic skeletal hyperostosis (DISH): where we are now and where to go next. RMD Open. 2017;3(1):e000472.
https://rmdopen.bmj.com/content/3/1/rmdopen-2017-000472
http://www.ncbi.nlm.nih.gov/pubmed/28955488?tool=bestpractice.com
HLA-B8 has also been noted to be present in some patients with DISH.[14]Belanger TA, Rowe DE. Diffuse idiopathic skeletal hyperostosis: musculoskeletal manifestations. J Am Acad Orthop Surg. 2001 Jul-Aug;9(4):258-67.
http://www.ncbi.nlm.nih.gov/pubmed/11476536?tool=bestpractice.com